Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Conditions
Interventions
- COMBINATION_PRODUCT: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator
- COMBINATION_PRODUCT: Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator
- COMBINATION_PRODUCT: Twice daily placebo suppository administered with Sephure applicator
Sponsor
Cristcot LLC
Collaborators